IL6 and cancer: However with the exception of TGF-β [31], we found no consistent significant increases in IL-10, IL-4, Il-13, Il-6, GM-CSF, G-CSF, or VEGF in the blood that could account for the failure across cancer patients (Supp Fig. 6A-F).